Adlai Nortye (ANL) Non-Current Assets (2022 - 2025)
Adlai Nortye's (ANL) quarterly Non-Current Assets came in at $7.5 million in Q4 2025, up 4.65% year-on-year from $7.2 million in Q4 2024, and up 14.81% on a QoQ basis from $6.6 million in Q2 2025.
Adlai Nortye (ANL) Non-Current Assets (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Non-Current Assets data on file, last reported at $7.5 million in Q4 2025.
- On a quarterly basis, Non-Current Assets rose 4.65% year-over-year to $7.5 million in Q4 2025; TTM through Jun 2025 was $6.6 million, a 11.24% decrease from a year earlier, with the FY2025 full-year figure at $7.5 million, up 4.65% from the prior year.
- Non-Current Assets for Q4 2025 stood at $7.5 million, up from $6.6 million in the prior quarter.
- Over the last five years, Non-Current Assets for ANL reached as high as $29.0 million in Q4 2023 and fell as low as $6.3 million in Q4 2022.
- Historically, Non-Current Assets has averaged $10.7 million across 4 years, with a median of $7.3 million in 2024.
- Across the five-year window, Non-Current Assets jumped 360.88% in 2023 and plunged 75.15% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $6.3 million in 2022, then soared by 360.88% to $29.0 million in 2023, then plunged by 75.15% to $7.2 million in 2024, then climbed by 4.65% to $7.5 million in 2025.
- Per Business Quant data, the three most recent Non-Current Assets figures were $7.5 million in Q4 2025, $6.6 million in Q2 2025, and $7.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 5.83 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.95 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 285.82 Mn |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | 7.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.54 Mn |
| Jun 30, 2025 | 6.57 Mn |
| Dec 31, 2024 | 7.21 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Dec 31, 2023 | 28.99 Mn |
| Dec 31, 2022 | 6.29 Mn |